![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1637, 2008-01, pp. : 18-18
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Denosumab HALTs bone loss during AI therapy for breast cancer
Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Weekly ibandronic acid prevents postmenopausal bone loss
Inpharma, Vol. 1, Iss. 1406, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Risedronic acid abrogates anastrozole-induced bone loss
Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. :